HOWARD SAFIR

CIK 1221559 · CEO, SC&I unit · last filed 2022-10-06

HOWARD SAFIR is a CEO, SC&I unit who has filed 49 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for CTXR, was dated Oct 6, 2022. Across all open-market trades the lifetime net is −$1.4M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

49

Lifetime Open-Market Net

-$1.39M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CTXR Director $0.54 $0 1 2022-10-06
Citius Pharmaceuticals, Inc. (CTXRW) Delisted Director $0.14 $0 8 2021-10-13
VERINT SYSTEMS INC (VRNT) Delisted Director 30,838 $20.51 $632.5K -$1.39M 31 2021-04-22
WALKER INNOVATION INC. (GLOI) Delisted CEO, SC&I unit 298,443 $0 2 2008-06-30

Recent Filings

49 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-10-06 CTXR Grant (A) $0 EDGAR
2021-10-13 Citius Pharmaceuticals, Inc. (CTXRW) Delisted Grant (A) $0 EDGAR
2021-07-26 Citius Pharmaceuticals, Inc. (CTXRW) Delisted Grant (A) $0 EDGAR
2021-04-22 VERINT SYSTEMS INC (VRNT) Delisted Grant (A) +4,178 $0 EDGAR
2021-02-18 Citius Pharmaceuticals, Inc. (CTXRW) Delisted Grant (A) $0 EDGAR
2020-12-16 VERINT SYSTEMS INC (VRNT) Delisted Sell (S) −8,333 -$501.7K EDGAR
2020-10-09 Citius Pharmaceuticals, Inc. (CTXRW) Delisted Grant (A) $0 EDGAR
2020-08-28 VERINT SYSTEMS INC (VRNT) Delisted Grant (A) +4,326 $0 EDGAR
2020-07-09 Citius Pharmaceuticals, Inc. (CTXRW) Delisted Grant (A) $0 EDGAR
2019-10-10 Citius Pharmaceuticals, Inc. (CTXRW) Delisted Grant (A) $0 EDGAR
Showing 110 of 49
Page 1 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.